Signature Wealth Management Group’s AstraZeneca AZN Stock Holding History

Signature Wealth Management Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-170	Closed	-$13K	–	89
2018 Q3	$13K	Hold	170	–	–	0.01%	165
2018 Q2	$12K	Hold	170	–	–	0.01%	168
2018 Q1	$12K	Sell	170 -67	-28%	-$4.64K	0.01%	165
2017 Q4	$16K	Buy	+237	New	+$16K	0.01%	157

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Signature Wealth Management Group's AZN Position: Q4 2018 in Review

Signature Wealth Management Group sold out of AstraZeneca (AZN) in Q4 2018, closing a stake of 170 shares — an estimated $13K sold.

Signature Wealth Management Group first reported a position in AZN in Q4 2017 and held it in 4 quarters. The position peaked at $16K in Q4 2017. 557 funds tracked by Wall St. Rank hold AZN as of Q4 2018.

Signature Wealth Management Group reported no remaining AstraZeneca position as of Q4 2018 after selling out during the quarter.
Signature Wealth Management Group sold 170 AstraZeneca shares in Q4 2018, an estimated $13K.
Signature Wealth Management Group first reported a position in AstraZeneca in Q4 2017 and held it in 4 quarters.
Signature Wealth Management Group's AstraZeneca position peaked at $16K in Q4 2017.
557 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2018.

Based on Signature Wealth Management Group's 13F filing for Q4 2018, filed 11 Feb 2019.